ALICIA NICKLAS: Open Payments
NPI 1487188256 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,032 in 218 payments from 27 companies in 2025. Trend: 2023 $1,240 · 2024 $2,742 · 2025 $3,032
Food & beverage: $3,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $790 |
| Neurocrine BioSciences, Inc. | 51 | $471 |
| PFIZER INC. | 16 | $212 |
| Lundbeck LLC | 10 | $204 |
| UCB, Inc. | 13 | $166 |
| Neurelis, Inc. | 8 | $155 |
| Lilly USA, LLC | 9 | $150 |
| Teva Pharmaceuticals USA, Inc. | 12 | $139 |
| EMD Serono, Inc. | 6 | $115 |
| ANI Pharmaceuticals, Inc. | 5 | $79 |
Products named: INGREZZA, QULIPTA, UBRELVY, VYEPTI, NURTEC ODT, VALTOCO, BOTOX, AUSTEDO XR.
Industry payments across LA — which companies pay providers there.
